269 related articles for article (PubMed ID: 32728730)
1. Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment.
Díaz-Román M; Pulopulos MM; Baquero M; Salvador A; Cuevas A; Ferrer I; Ciopat O; Gómez E
Sleep; 2021 Jan; 44(1):. PubMed ID: 32728730
[TBL] [Abstract][Full Text] [Related]
2. Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer's Disease Biomarkers Changes.
Liguori C; Mercuri NB; Izzi F; Romigi A; Cordella A; Sancesario G; Placidi F
Sleep; 2017 May; 40(5):. PubMed ID: 28329084
[TBL] [Abstract][Full Text] [Related]
3. Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk?
Liguori C; Mercuri NB; Nuccetelli M; Izzi F; Cordella A; Bernardini S; Placidi F
Sleep Med; 2019 Apr; 56():171-176. PubMed ID: 30799255
[TBL] [Abstract][Full Text] [Related]
4. Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes.
Bubu OM; Pirraglia E; Andrade AG; Sharma RA; Gimenez-Badia S; Umasabor-Bubu OQ; Hogan MM; Shim AM; Mukhtar F; Sharma N; Mbah AK; Seixas AA; Kam K; Zizi F; Borenstein AR; Mortimer JA; Kip KE; Morgan D; Rosenzweig I; Ayappa I; Rapoport DM; Jean-Louis G; Varga AW; Osorio RS;
Sleep; 2019 Jun; 42(6):. PubMed ID: 30794315
[TBL] [Abstract][Full Text] [Related]
5. Association between obstructive sleep apnea and Alzheimer's disease-related blood and cerebrospinal fluid biomarkers: A meta-analysis.
Kang J; Tian Z; Wei J; Mu Z; Liang J; Li M
J Clin Neurosci; 2022 Aug; 102():87-94. PubMed ID: 35753156
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
Yang Y; Li M; Leng B; Yao R; Xue S; Tan M; Sun H; Zhang J
J Alzheimers Dis; 2023; 95(4):1685-1696. PubMed ID: 37718794
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
[TBL] [Abstract][Full Text] [Related]
8. Altered amyloid-β and tau proteins in neural-derived plasma exosomes in obstructive sleep apnea.
Sun H; Gao Y; Li M; Zhang S; Shen T; Yuan X; Shang X; Li Z; Zhang J
Sleep Med; 2022 Jun; 94():76-83. PubMed ID: 35504110
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research.
Bubu OM; Andrade AG; Umasabor-Bubu OQ; Hogan MM; Turner AD; de Leon MJ; Ogedegbe G; Ayappa I; Jean-Louis G G; Jackson ML; Varga AW; Osorio RS
Sleep Med Rev; 2020 Apr; 50():101250. PubMed ID: 31881487
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
[TBL] [Abstract][Full Text] [Related]
12. Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Kresge HA; Liu D; Gupta DK; Moore EE; Osborn KE; Acosta LMY; Bell SP; Pechman KR; Gifford KA; Mendes LA; Wang TJ; Blennow K; Zetterberg H; Hohman TJ; Jefferson AL
J Alzheimers Dis; 2020; 74(3):965-974. PubMed ID: 32144980
[TBL] [Abstract][Full Text] [Related]
13. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
14. Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.
Osorio RS; Ducca EL; Wohlleber ME; Tanzi EB; Gumb T; Twumasi A; Tweardy S; Lewis C; Fischer E; Koushyk V; Cuartero-Toledo M; Sheikh MO; Pirraglia E; Zetterberg H; Blennow K; Lu SE; Mosconi L; Glodzik L; Schuetz S; Varga AW; Ayappa I; Rapoport DM; de Leon MJ
Sleep; 2016 Jun; 39(6):1253-60. PubMed ID: 26951396
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
18. Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.
Elias A; Cummins T; Tyrrell R; Lamb F; Dore V; Williams R; Rosenfeld JV; Hopwood M; Villemagne VL; Rowe CC
J Alzheimers Dis; 2018; 66(2):733-741. PubMed ID: 30320587
[TBL] [Abstract][Full Text] [Related]
19. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
[TBL] [Abstract][Full Text] [Related]
20. Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease.
Alexopoulos P; Werle L; Roesler J; Thierjung N; Gleixner LS; Yakushev I; Laskaris N; Wagenpfeil S; Gourzis P; Kurz A; Perneczky R;
Alzheimers Res Ther; 2016 Dec; 8(1):51. PubMed ID: 27931251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
